Search
The FDA has approved nirogacestat (OgsiveoTM), a targeted therapy for desmoid tumors. A recent phase 3 clinical trial found that the drug significantly shrank desmoid tumors in 41% of patients. Desmoid tumors (also known as aggressive fibromatosis) are a rare type of soft tissue tumor.
Women on Long Island who don’t have insurance or who are underinsured may be able to take advantage of free mammograms at Memorial Sloan Kettering Cancer Center Commack.
A therapy made of immune system T cells engineered to target a somewhat enigmatic cell protein called GPRC5D antigen produced impressive results in its first clinical trial in patients with multiple myeloma, researchers at Memorial Sloan Kettering Cancer Center (MSK), Dana-Farber Cancer Institute, and Roswell Park Comprehensive Cancer Center report in a new study.
Memorial Sloan Kettering cell biologist Emily Foley discusses her research, which is focused on improving the understanding of cell division.
Gerstner Sloan Kettering student Elizabeth Wasmuth has been awarded the Chairman’s Prize for her paper published in Nature in 2014, on which she was the first author.
The American College of Surgeons recently designated Memorial Sloan Kettering Cancer Center (MSK) the first-ever Children’s Surgery Verification (CSV) Quality Improvement Program Level I Specialty Children’s Surgery Center in Oncology. The distinction recognizes MSK as a highly specialized hospital providing exceptional surgical care that matches children’s needs with optimal pediatric resources.
Memorial Sloan Kettering Cancer Center’s (MSK) Deputy Chief Nursing Officer, Kevin P. Browne, DNP, RN, CNS, CCRN, was named the recipient of the 2021 Firefighter Thomas Phelan Memorial Award by the Irish American Building Society (IABS).
An analysis of patients with Lynch syndrome treated at MSK finds that immunotherapy drugs called checkpoint inhibitors may prevent serious tumors from forming.
MSK scientists have created a mouse model that replicates a subtype of non-small cell lung cancer caused by a chromosomal rearrangement.
Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments.